-
1
-
-
0028376072
-
Renal vascular complications of systemic lupus erythematosus
-
COI: 1:STN:280:DyaK2c3pslWmtg%3D%3D, PID: 8025223
-
Appel GB, Pirani CL, D'Agati V (1994) Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4(8):1499–1515
-
(1994)
J Am Soc Nephrol
, vol.4
, Issue.8
, pp. 1499-1515
-
-
Appel, G.B.1
Pirani, C.L.2
D'Agati, V.3
-
2
-
-
0025989985
-
Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)
-
COI: 1:STN:280:DyaK3MzivVWhsA%3D%3D, PID: 1867181
-
Banfi G, Bertani T, Boeri V et al (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18(2):240–248
-
(1991)
Am J Kidney Dis
, vol.18
, Issue.2
, pp. 240-248
-
-
Banfi, G.1
Bertani, T.2
Boeri, V.3
-
3
-
-
0021986361
-
Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus
-
COI: 1:STN:280:DyaL2M7ivFWitw%3D%3D, PID: 3972386
-
Tsumagari T, Fukumoto S, Kinjo M, Tanaka K (1985) Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus. Hum Pathol 16(1):43–49
-
(1985)
Hum Pathol
, vol.16
, Issue.1
, pp. 43-49
-
-
Tsumagari, T.1
Fukumoto, S.2
Kinjo, M.3
Tanaka, K.4
-
4
-
-
78649643417
-
Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy
-
COI: 1:CAS:528:DC%2BC3MXlslartQ%3D%3D, PID: 20798137
-
Hu WX, Liu ZZ, Chen HP, Zhang HT, Li LS, Liu ZH (2010) Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy. Lupus 19(14):1591–1598
-
(2010)
Lupus
, vol.19
, Issue.14
, pp. 1591-1598
-
-
Hu, W.X.1
Liu, Z.Z.2
Chen, H.P.3
Zhang, H.T.4
Li, L.S.5
Liu, Z.H.6
-
5
-
-
84940363650
-
Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications
-
PID: 24382968
-
Vieregge GB, Harrington TJ, Andrews DM, Carpintero MF, Green DF, Nayer A (2013) Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications. Case Rep Med 2013:915309
-
(2013)
Case Rep Med
, vol.2013
, pp. 915309
-
-
Vieregge, G.B.1
Harrington, T.J.2
Andrews, D.M.3
Carpintero, M.F.4
Green, D.F.5
Nayer, A.6
-
6
-
-
84896544929
-
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends
-
COI: 1:CAS:528:DC%2BC2cXis1CrtLc%3D, PID: 24468415
-
Erkan D, Aguiar CL, Andrade D et al (2014) 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13(6):685–696
-
(2014)
Autoimmun Rev
, vol.13
, Issue.6
, pp. 685-696
-
-
Erkan, D.1
Aguiar, C.L.2
Andrade, D.3
-
7
-
-
84921888665
-
Catastrophic APS in the context of other thrombotic microangiopathies
-
PID: 25604575
-
Rodriguez-Pinto I, Espinosa G, Cervera R (2015) Catastrophic APS in the context of other thrombotic microangiopathies. Curr Rheumatol Rep 17(1):482
-
(2015)
Curr Rheumatol Rep
, vol.17
, Issue.1
, pp. 482
-
-
Rodriguez-Pinto, I.1
Espinosa, G.2
Cervera, R.3
-
8
-
-
84936987706
-
36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature
-
PID: 25389502
-
Strakhan M, Hurtado-Sbordoni M, Galeas N, Bakirhan K, Alexis K, Elrafei T (2014) 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature. Case Rep Hematol 2014:704371
-
(2014)
Case Rep Hematol
, vol.2014
, pp. 704371
-
-
Strakhan, M.1
Hurtado-Sbordoni, M.2
Galeas, N.3
Bakirhan, K.4
Alexis, K.5
Elrafei, T.6
-
9
-
-
84895064562
-
Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation
-
COI: 1:CAS:528:DC%2BC2cXhs1eqsbc%3D, PID: 24400968
-
Lonze BE, Zachary AA, Magro CM et al (2014) Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant 14(2):459–465
-
(2014)
Am J Transplant
, vol.14
, Issue.2
, pp. 459-465
-
-
Lonze, B.E.1
Zachary, A.A.2
Magro, C.M.3
-
10
-
-
0028567103
-
Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus
-
COI: 1:STN:280:DyaK2M3gslOkuw%3D%3D, PID: 7899874
-
Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG (1994) Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 24(3):165–172
-
(1994)
Semin Arthritis Rheum
, vol.24
, Issue.3
, pp. 165-172
-
-
Nesher, G.1
Hanna, V.E.2
Moore, T.L.3
Hersh, M.4
Osborn, T.G.5
-
11
-
-
84969872350
-
Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study
-
COI: 1:CAS:528:DC%2BC28Xns1aksr0%3D
-
Li QY, Yu F, Zhou FD, Zhao MH (2016) Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study. Medicine (Baltimore) 95(18):e3595
-
(2016)
Medicine (Baltimore)
, vol.95
, Issue.18
-
-
Li, Q.Y.1
Yu, F.2
Zhou, F.D.3
Zhao, M.H.4
-
12
-
-
84884971310
-
Eculizumab in atypical hemolytic-uremic syndrome
-
COI: 1:CAS:528:DC%2BC3sXhsF2ksbrN, PID: 24088105
-
Legendre CM, Licht C, Loirat C (2013) Eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 369(14):1379–1380
-
(2013)
N Engl J Med
, vol.369
, Issue.14
, pp. 1379-1380
-
-
Legendre, C.M.1
Licht, C.2
Loirat, C.3
-
13
-
-
84857190406
-
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation
-
COI: 1:CAS:528:DC%2BC3MXhsFCmtLvM, PID: 21831149
-
Hadaya K, Ferrari-Lacraz S, Fumeaux D et al (2011) Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant 11(11):2523–2527
-
(2011)
Am J Transplant
, vol.11
, Issue.11
, pp. 2523-2527
-
-
Hadaya, K.1
Ferrari-Lacraz, S.2
Fumeaux, D.3
-
14
-
-
84864485595
-
Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
-
COI: 1:CAS:528:DC%2BC38XhtV2gtLfN, PID: 22354668
-
Shapira I, Andrade D, Allen SL, Salmon JE (2012) Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis Rheum 64(8):2719–2723
-
(2012)
Arthritis Rheum
, vol.64
, Issue.8
, pp. 2719-2723
-
-
Shapira, I.1
Andrade, D.2
Allen, S.L.3
Salmon, J.E.4
-
15
-
-
84881372189
-
Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes
-
COI: 1:CAS:528:DC%2BC3sXhsVersb%2FO, PID: 23763583
-
Canaud G, Kamar N, Anglicheau D et al (2013) Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes. Am J Transplant 13(8):2179–2185
-
(2013)
Am J Transplant
, vol.13
, Issue.8
, pp. 2179-2185
-
-
Canaud, G.1
Kamar, N.2
Anglicheau, D.3
-
16
-
-
84917728306
-
Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report
-
COI: 1:CAS:528:DC%2BC2cXitVKrsbnL
-
Kronbichler A, Frank R, Kirschfink M et al (2014) Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report. Medicine (Baltimore) 93(26):e143
-
(2014)
Medicine (Baltimore)
, vol.93
, Issue.26
-
-
Kronbichler, A.1
Frank, R.2
Kirschfink, M.3
-
17
-
-
84920942686
-
Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy
-
PID: 25173358
-
Coppo R, Peruzzi L, Amore A et al (2015) Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. Pediatr Nephrol 30(1):167–172
-
(2015)
Pediatr Nephrol
, vol.30
, Issue.1
, pp. 167-172
-
-
Coppo, R.1
Peruzzi, L.2
Amore, A.3
-
18
-
-
84905733420
-
A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab
-
PID: 25089339
-
Bakhtar O, Thajudeen B, Braunhut BL et al (2014) A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab. Transplantation 98(3):e17–e18
-
(2014)
Transplantation
, vol.98
, Issue.3
, pp. e17-e18
-
-
Bakhtar, O.1
Thajudeen, B.2
Braunhut, B.L.3
-
19
-
-
84940905884
-
Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome
-
PID: 26267719
-
Zikos TA, Sokolove J, Ahuja N, Berube C (2015) Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome. J Clin Rheumatol 21(6):311–313
-
(2015)
J Clin Rheumatol
, vol.21
, Issue.6
, pp. 311-313
-
-
Zikos, T.A.1
Sokolove, J.2
Ahuja, N.3
Berube, C.4
-
20
-
-
84961960857
-
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor
-
Wig S, Chan M, Thachil J, Bruce I, Barnes T (2016) A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor. Rheumatology (Oxford) 55(2):382–384
-
(2016)
Rheumatology (Oxford)
, vol.55
, Issue.2
, pp. 382-384
-
-
Wig, S.1
Chan, M.2
Thachil, J.3
Bruce, I.4
Barnes, T.5
-
21
-
-
84922373286
-
Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab
-
COI: 1:CAS:528:DC%2BC2cXhvFarsLnI, PID: 25446020
-
El-Husseini A, Hannan S, Awad A, Jennings S, Cornea V, Sawaya BP (2015) Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. Am J Kidney Dis 65(1):127–130
-
(2015)
Am J Kidney Dis
, vol.65
, Issue.1
, pp. 127-130
-
-
El-Husseini, A.1
Hannan, S.2
Awad, A.3
Jennings, S.4
Cornea, V.5
Sawaya, B.P.6
-
22
-
-
84983094382
-
Eculizumab as rescue therapy in severe resistant lupus nephritis
-
Pickering MC, Ismajli M, Condon MB et al (2015) Eculizumab as rescue therapy in severe resistant lupus nephritis. Rheumatology (Oxford) 54(12):2286–2288
-
(2015)
Rheumatology (Oxford)
, vol.54
, Issue.12
, pp. 2286-2288
-
-
Pickering, M.C.1
Ismajli, M.2
Condon, M.B.3
-
23
-
-
84990829817
-
Atypical hemolytic uremic syndrome secondary to lupus nephritis, responsive to eculizumab
-
PID: 27781079
-
Raufi AG, Scott S, Darwish O et al (2016) Atypical hemolytic uremic syndrome secondary to lupus nephritis, responsive to eculizumab. Hematol Rep 8(3):6625
-
(2016)
Hematol Rep
, vol.8
, Issue.3
, pp. 6625
-
-
Raufi, A.G.1
Scott, S.2
Darwish, O.3
-
24
-
-
84986207697
-
Use of eculizumab in atypical hemolytic uremic syndrome, complicating systemic lupus erythematosus
-
PID: 27556240
-
Bermea RS, Sharma N, Cohen K, Liarski VM (2016) Use of eculizumab in atypical hemolytic uremic syndrome, complicating systemic lupus erythematosus. J Clin Rheumatol 22(6):320–323
-
(2016)
J Clin Rheumatol
, vol.22
, Issue.6
, pp. 320-323
-
-
Bermea, R.S.1
Sharma, N.2
Cohen, K.3
Liarski, V.M.4
-
25
-
-
85017435720
-
Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome
-
Geethakumari PR, Mille P, Gulati R, Nagalla S. (2017) Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome. Transfus Apher Sci 56(3):400–403
-
(2017)
Transfus Apher Sci
, vol.56
, Issue.3
, pp. 400-403
-
-
Geethakumari, P.R.1
Mille, P.2
Gulati, R.3
Nagalla, S.4
-
26
-
-
0025773511
-
Significance of anti-phospholipid antibodies in patients with lupus nephritis
-
COI: 1:STN:280:DyaK3MznsV2ktw%3D%3D, PID: 1716712
-
Frampton G, Hicks J, Cameron JS (1991) Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int 39(6):1225–1231
-
(1991)
Kidney Int
, vol.39
, Issue.6
, pp. 1225-1231
-
-
Frampton, G.1
Hicks, J.2
Cameron, J.S.3
-
27
-
-
34548416651
-
Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies
-
Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P (2007) Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology (Carlton) 12(5):474–480
-
(2007)
Nephrology (Carlton)
, vol.12
, Issue.5
, pp. 474-480
-
-
Cheunsuchon, B.1
Rungkaew, P.2
Chawanasuntorapoj, R.3
Pattaragarn, A.4
Parichatikanond, P.5
-
28
-
-
2442701758
-
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies
-
COI: 1:STN:280:DC%2BD2c3ktFKgug%3D%3D, PID: 15140782
-
Espinosa G, Bucciarelli S, Cervera R et al (2004) Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63(6):730–736
-
(2004)
Ann Rheum Dis
, vol.63
, Issue.6
, pp. 730-736
-
-
Espinosa, G.1
Bucciarelli, S.2
Cervera, R.3
-
29
-
-
4043055247
-
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome
-
PID: 15334471
-
Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569–2579
-
(2004)
Arthritis Rheum
, vol.50
, Issue.8
, pp. 2569-2579
-
-
Tektonidou, M.G.1
Sotsiou, F.2
Nakopoulou, L.3
Vlachoyiannopoulos, P.G.4
Moutsopoulos, H.M.5
-
30
-
-
84939541475
-
Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome
-
PID: 26203932
-
Hernandez-Molina G, Garcia-Trejo LP, Uribe N, Cabral AR (2015) Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome. Clin Exp Rheumatol 33(4):503–508
-
(2015)
Clin Exp Rheumatol
, vol.33
, Issue.4
, pp. 503-508
-
-
Hernandez-Molina, G.1
Garcia-Trejo, L.P.2
Uribe, N.3
Cabral, A.R.4
-
31
-
-
0034650431
-
Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B
-
COI: 1:CAS:528:DC%2BD3cXlt1CmtA%3D%3D, PID: 10623824
-
Watanabe H, Garnier G, Circolo A et al (2000) Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 164(2):786–794
-
(2000)
J Immunol
, vol.164
, Issue.2
, pp. 786-794
-
-
Watanabe, H.1
Garnier, G.2
Circolo, A.3
-
32
-
-
0035793334
-
Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin
-
COI: 1:CAS:528:DC%2BD3MXhtVaisrc%3D, PID: 11157679
-
Pierangeli SS, Espinola RG, Liu X, Harris EN (2001) Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 88(2):245–250
-
(2001)
Circ Res
, vol.88
, Issue.2
, pp. 245-250
-
-
Pierangeli, S.S.1
Espinola, R.G.2
Liu, X.3
Harris, E.N.4
-
33
-
-
0036137594
-
Antiphospholipid syndrome nephropathy in systemic lupus erythematosus
-
PID: 11752020
-
Daugas E, Nochy D, Huong DL et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13(1):42–52
-
(2002)
J Am Soc Nephrol
, vol.13
, Issue.1
, pp. 42-52
-
-
Daugas, E.1
Nochy, D.2
Huong, D.L.3
-
34
-
-
0032979820
-
The intrarenal vascular lesions associated with primary antiphospholipid syndrome
-
COI: 1:STN:280:DyaK1M7ntFKjuw%3D%3D, PID: 10073601
-
Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10(3):507–518
-
(1999)
J Am Soc Nephrol
, vol.10
, Issue.3
, pp. 507-518
-
-
Nochy, D.1
Daugas, E.2
Droz, D.3
-
35
-
-
84899104450
-
Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients
-
COI: 1:CAS:528:DC%2BC2cXmvVyrs7k%3D
-
Jordan N, Chaib A, Sangle S et al (2014) Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients. Arthritis Care Res (Hoboken) 66(5):725–731
-
(2014)
Arthritis Care Res (Hoboken)
, vol.66
, Issue.5
, pp. 725-731
-
-
Jordan, N.1
Chaib, A.2
Sangle, S.3
-
36
-
-
84897051550
-
Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study
-
COI: 1:CAS:528:DC%2BC3sXhsl2jsbvI, PID: 24232504
-
Erre GL, Bosincu L, Faedda R et al (2014) Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatol Int 34(4):535–541
-
(2014)
Rheumatol Int
, vol.34
, Issue.4
, pp. 535-541
-
-
Erre, G.L.1
Bosincu, L.2
Faedda, R.3
-
37
-
-
84872140900
-
The spectrum of renal thrombotic microangiopathy in lupus nephritis
-
COI: 1:CAS:528:DC%2BC3sXnvFaiu7Y%3D, PID: 23320601
-
Song D, Wu LH, Wang FM et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15(1):R12
-
(2013)
Arthritis Res Ther
, vol.15
, Issue.1
, pp. R12
-
-
Song, D.1
Wu, L.H.2
Wang, F.M.3
-
38
-
-
0037700599
-
Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells
-
COI: 1:CAS:528:DC%2BD3sXmsl2qt7Y%3D, PID: 12892395
-
Pierangeli SS, Harris EN (2003) Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 12(7):539–545
-
(2003)
Lupus
, vol.12
, Issue.7
, pp. 539-545
-
-
Pierangeli, S.S.1
Harris, E.N.2
-
39
-
-
79953321819
-
Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
-
COI: 1:STN:280:DC%2BC3M7nvVWqsw%3D%3D, PID: 21303833
-
Cervera R, Tektonidou MG, Espinosa G et al (2011) Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20(2):165–173
-
(2011)
Lupus
, vol.20
, Issue.2
, pp. 165-173
-
-
Cervera, R.1
Tektonidou, M.G.2
Espinosa, G.3
-
40
-
-
49449092487
-
Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis
-
PID: 18668574
-
Cohen D, Koopmans M, Kremer Hovinga IC et al (2008) Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 58(8):2460–2469
-
(2008)
Arthritis Rheum
, vol.58
, Issue.8
, pp. 2460-2469
-
-
Cohen, D.1
Koopmans, M.2
Kremer Hovinga, I.C.3
-
41
-
-
84855765646
-
Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus
-
PID: 22171659
-
Jonsen A, Nilsson SC, Ahlqvist E et al (2011) Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res Ther 13(6):R206
-
(2011)
Arthritis Res Ther
, vol.13
, Issue.6
, pp. R206
-
-
Jonsen, A.1
Nilsson, S.C.2
Ahlqvist, E.3
-
42
-
-
85017040990
-
High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies
-
COI: 1:CAS:528:DC%2BC28XitFSjtLzO, PID: 26283675
-
Bu F, Borsa NG, Jones MB et al (2016) High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies. J Am Soc Nephrol 27(4):1245–1253
-
(2016)
J Am Soc Nephrol
, vol.27
, Issue.4
, pp. 1245-1253
-
-
Bu, F.1
Borsa, N.G.2
Jones, M.B.3
-
43
-
-
84878589219
-
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
-
COI: 1:CAS:528:DC%2BC3sXpt1Oqu7k%3D, PID: 23738544
-
Legendre CM, Licht C, Muus P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368(23):2169–2181
-
(2013)
N Engl J Med
, vol.368
, Issue.23
, pp. 2169-2181
-
-
Legendre, C.M.1
Licht, C.2
Muus, P.3
-
44
-
-
84992309323
-
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
-
PID: 27110144
-
Palma LM, Langman CB (2016) Critical appraisal of eculizumab for atypical hemolytic uremic syndrome. J Blood Med 7:39–72
-
(2016)
J Blood Med
, vol.7
, pp. 39-72
-
-
Palma, L.M.1
Langman, C.B.2
-
45
-
-
77951853702
-
Eculizumab and renal transplantation in a patient with CAPS
-
COI: 1:CAS:528:DC%2BC3cXls1yksbg%3D, PID: 20445191
-
Lonze BE, Singer AL, Montgomery RA (2010) Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med 362(18):1744–1745
-
(2010)
N Engl J Med
, vol.362
, Issue.18
, pp. 1744-1745
-
-
Lonze, B.E.1
Singer, A.L.2
Montgomery, R.A.3
-
46
-
-
0035021077
-
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis
-
COI: 1:STN:280:DC%2BD3M3psF2qug%3D%3D, PID: 11380817
-
Najafi CC, Korbet SM, Lewis EJ et al (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59(6):2156–2163
-
(2001)
Kidney Int
, vol.59
, Issue.6
, pp. 2156-2163
-
-
Najafi, C.C.1
Korbet, S.M.2
Lewis, E.J.3
-
47
-
-
84929128976
-
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
-
COI: 1:CAS:528:DC%2BC2MXotVCisLY%3D, PID: 25651368
-
Licht C, Greenbaum LA, Muus P et al (2015) Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int 87(5):1061–1073
-
(2015)
Kidney Int
, vol.87
, Issue.5
, pp. 1061-1073
-
-
Licht, C.1
Greenbaum, L.A.2
Muus, P.3
|